期刊
NEURON
卷 104, 期 5, 页码 885-+出版社
CELL PRESS
DOI: 10.1016/j.neuron.2019.09.003
关键词
-
资金
- NIH [R35GM124824, R01NS107347, 1DP2HD084069-01, R01NS101986]
- Target ALS
- Packard Center for ALS Research
- ALS Association
- Target ALS Foundation
- Muscular Dystrophy Association
- AAN/ALSA Clinician Scientist Development Award in ALS Research
- American Heart Association [19POST34430035]
- BrightFocus Foundation [A2019612F]
Hexanucleotide GGGGCC repeat expansion in C9ORF72 is the most prevalent genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). One pathogenic mechanism is the aberrant accumulation of dipeptide repeat (DPR) proteins produced by the unconventional translation of expanded RNA repeats. Here, we performed genome-wide CRISPR-Cas9 screens for modifiers of DPR protein production in human cells. We found that DDX3X, an RNA helicase, suppresses the repeat-associated non-AUG translation of GGGGCC repeats. DDX3X directly binds to (GGGGCC)n RNAs but not antisense (CCCCGG)n RNAs. Its helicase activity is essential for the translation repression. Reduction of DDX3X increases DPR levels in C9ORF72-ALS/FTD patient cells and enhances (GGGGCC)n-mediated toxicity in Drosophila. Elevating DDX3X expression is sufficient to decrease DPR levels, rescue nucleocytoplasmic transport abnormalities, and improve survival of patient iPSC-differentiated neurons. This work identifies genetic modifiers of DPR protein production and provides potential therapeutic targets for C9ORF72-ALS/FTD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据